Abiopharma

Driscoll Cindy 🟢 acquired 100.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007662

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Director SUN ANTHONY 🟡 adjusted position in 99.2K shares (7 derivative) of COGNEX CORP (CGNX) at $56.44 ($5.1M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Icecure Medical Ltd (ICCM) Files Form 6-K

RENTON HOLLINGS 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Veeva to Present at the J.P. Morgan 2026 Healthcare Conference

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Spyre Therapeutics Announces Grants of Inducement Awards